Arena Pharmaceuticals, Inc. Contract with Customer, Asset, after Allowance for Credit Loss, Current
Arena Pharmaceuticals, Inc. had Contract with Customer, Asset, after Allowance for Credit Loss, Current of $1.43 million as of 2019-09-30, per its 10-Q filed 2019-11-08.
Discontinued › Balance Sheet › Assets › Assets, Current
us-gaap:ContractWithCustomerAssetNetCurrent · last filed 2019-11-08
- 2019-09-30: Contract with Customer, Asset, after Allowance for Credit Loss, Current $1.43M.
- 2019-06-30: Contract with Customer, Asset, after Allowance for Credit Loss, Current $1.45M.
- 2019-03-31: Contract with Customer, Asset, after Allowance for Credit Loss, Current $1.47M.
- 2018-12-31: Contract with Customer, Asset, after Allowance for Credit Loss, Current $1.48M.
| Period end | Contract with Customer, Asset, after Allowance for Credit Loss, Current |
|---|---|
| 2019-09-30 | $1.43M 10-Q · filed 2019-11-08 |
| 2019-06-30 | $1.45M 10-Q · filed 2019-08-09 |
| 2019-03-31 | $1.47M 10-Q · filed 2019-05-09 |
| 2018-12-31 | $1.48M 10-Q · filed 2019-11-08 |
| 2018-09-30 | $1.31M 10-Q · filed 2018-11-08 |
| 2018-06-30 | $1.06M 10-Q · filed 2018-08-07 |
| 2018-03-31 | $1.15M 10-Q · filed 2018-05-09 |
| 2018-01-01 | $1.40M 10-K · filed 2019-02-28 |
| 2017-12-31 | $1.40M 10-Q · filed 2018-11-08 |